Shocking discovery! Counterfeit drugs implicated in Alkem Laboratories investigation—What you need to know
In a shocking turn of events, Alkem Laboratories has uncovered that counterfeit drugs have been implicated in an ongoing investigation involving two of its popular ... Read More
Torrent Pharmaceuticals denies counterfeit allegations around Shelcal 500
Torrent Pharmaceuticals Limited, one of India’s leading pharmaceutical companies, has strongly refuted claims surrounding the quality of its popular product Shelcal 500. In a statement ... Read More
Zydus advances PCSK9 inhibitor with Phase I clinical study approval
Zydus, a global pharmaceutical company, has secured permission from CDSCO, India, to kickstart the Phase I clinical study of its groundbreaking PCSK9 inhibitor. This Phase ... Read More
BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard ... Read More
Bharat Parenterals gets license and authorization for Favipiravir oral suspension for Covid treatment
Bharat Parenterals said that it has secured the license and authorization from Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organisation (CDSCO) ... Read More
Torrent Pharma signs licensing deal with Lilly for Covid drug baricitinib
Torrent Pharmaceuticals (Torrent Pharma) has signed a licensing agreement with Eli Lilly and Company with an objective to bring the latter’s baricitinib for Covid-19 treatment ... Read More
Roche, Cipla to bring Casirivimab/Imdevimab Covid-19 drug to India
Roche India said that India’s Central Drugs Standards Control Organisation (CDSCO) has granted an emergency use authorisation (EUA) for the Casirivimab, Imdevimab antibody cocktail for ... Read More
Natco Pharma gets CDSCO nod for use of Baricitinib in Covid patients
Natco Pharma has secured emergency use approval for Baricitinib from India’s Central Drugs Standard Control Organization (CDSCO) for the treatment of Covid-19. The Indian pharma ... Read More
India approves Saragene COVID-19 2-gene multiplex RT-PCR test
CoSara Diagnostics has secured clearance from the Indian Central Drugs Standard Control Organization (CDSCO) to manufacture and sell its Saragene COVID-19 2-gene multiplex RT-PCR test. ... Read More
India’s CDSCO grants APAC Biotech license for immuno-oncology drug Apceden
The Central Drugs Standard Control Organization (CDSCO), India's regulatory authority, has granted a commercial license to APAC Biotech for the marketing of Apceden, a Dendritic ... Read More